Formation Bio CEO Ben Liu on Fixing the Bottleneck Slowing Down Medicine
Podcasts
•
19m
Formation Bio is rewriting the rules of drug development at a time when AI is accelerating drug discovery far faster than the industry can bring new therapies to patients. CEO Ben Liu goes Inside the ICE House to explain why the real bottleneck in pharma isn't finding promising drug candidates, it's developing them efficiently and at scale. He unpacks Formation Bio's AI-native model, which acquires already-discovered drugs and deploys proprietary tools to optimize trial design, predict clinical outcomes, and identify overlooked disease indications.
Up Next in Podcasts
-
Horizon Head of Product Clark Allen
Clark Allen, Head of Product at Horizon Investments, joins Bilal Little on ETF Central to discuss the firm's rapid growth to more than $4 billion in ETF assets and its advisor-first approach to product development. Allen shares his journey from CPA and quantitative researcher to leading Horizon's...
-
Third Coast Bank CEO Bart Caraway on ...
Third Coast Bancshares Founder and CEO Bart Caraway joins Inside the ICE House to discuss building a Texas-based community bank from a vision into a publicly traded company now listed on the New York Stock Exchange. He reflects on launching the bank in 2008 at the onset of the Great Recession and...
-
8-20-2026: Middle East Tensions, Trea...
Michael Reinking, Senior Market Strategist at the NYSE, recaps a week dominated by Treasury Secretary Bessent, whose doubled liquidity support buybacks reignited the debasement trade, sending gold back above 4,500 and triggering a massive crypto short squeeze that propelled Bitcoin up ~15% and Et...
